{"title":"Microscopical contaminant monitoring. I. Particulate matter as viewed by the FDA.","authors":"G Schwartzman","doi":"","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":75655,"journal":{"name":"Bulletin of the Parenteral Drug Association","volume":"31 4","pages":"161-5"},"PeriodicalIF":0.0000,"publicationDate":"1977-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bulletin of the Parenteral Drug Association","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}